Skip to main content

Main menu

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
American Society of Nephrology
  • Other
    • ASN Publications
    • JASN
    • Kidney360
    • Kidney News Online
    • American Society of Nephrology
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Advertisement
American Society of Nephrology

Advanced Search

  • Home
  • Content
    • Published Ahead of Print
    • Current Issue
    • Podcasts
    • Subject Collections
    • Archives
    • Kidney Week Abstracts
    • Saved Searches
  • Authors
    • Submit a Manuscript
    • Author Resources
  • Trainees
    • Peer Review Program
    • Prize Competition
  • About CJASN
    • About CJASN
    • Editorial Team
    • CJASN Impact
    • CJASN Recognitions
  • More
    • Alerts
    • Advertising
    • Feedback
    • Reprint Information
    • Subscriptions
  • ASN Kidney News
  • Visit ASN on Facebook
  • Follow CJASN on Twitter
  • CJASN RSS
  • Community Forum

cystic kidney

  • Open Access
    Changing Health Disparities in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
    Suzanne F. Ruff
    CJASN June 2022, CJN.05790522; DOI: https://doi.org/10.2215/CJN.05790522
    Add to Selected Citations
  • Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
    Open Access
    Multicenter Study of Long-Term Safety of Tolvaptan in Later-Stage Autosomal Dominant Polycystic Kidney Disease
    Vicente E. Torres, Arlene B. Chapman, Olivier Devuyst, Ron T. Gansevoort, Ronald D. Perrone, Jennifer Lee, Molly E. Hoke, Alvin Estilo and Olga Sergeyeva
    CJASN January 2021, 16 (1) 48-58; DOI: https://doi.org/10.2215/CJN.10250620
    Add to Selected Citations
  • You have accessRestricted Access
    ADPKD, Tolvaptan, and Nephrolithiasis Risk
    Ewout J. Hoorn and Robert Zietse
    CJASN July 2020, 15 (7) 923-925; DOI: https://doi.org/10.2215/CJN.07610520
    Add to Selected Citations
  • Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease
    You have accessRestricted Access
    Growth Pattern of Kidney Cyst Number and Volume in Autosomal Dominant Polycystic Kidney Disease
    Kyongtae T. Bae, Wen Zhou, Chengli Shen, Douglas P. Landsittel, Zhiyuan Wu, Cheng Tao, Arlene B. Chapman, Vicente E. Torres, Alan S.L. Yu, Michal Mrug, William M. Bennett, Peter C. Harris and for the Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP)
    CJASN June 2019, 14 (6) 823-833; DOI: https://doi.org/10.2215/CJN.10360818
    Add to Selected Citations
  • You have accessRestricted Access
    Prospective Evaluation of Kidney Disease in Joubert Syndrome
    Leah R. Fleming, Daniel A. Doherty, Melissa A. Parisi, Ian A. Glass, Joy Bryant, Roxanne Fischer, Baris Turkbey, Peter Choyke, Kailash Daryanani, Meghana Vemulapalli, James C. Mullikin, May Christine Malicdan, Thierry Vilboux, John A. Sayer, William A. Gahl and Meral Gunay-Aygun
    CJASN December 2017, 12 (12) 1962-1973; DOI: https://doi.org/10.2215/CJN.05660517
    Add to Selected Citations
  • You have accessRestricted Access
    Transcriptional Complexity in Autosomal Recessive Polycystic Kidney Disease
    Valeska Frank, Klaus Zerres and Carsten Bergmann
    CJASN October 2014, 9 (10) 1729-1736; DOI: https://doi.org/10.2215/CJN.00920114
    Add to Selected Citations
  • You have accessRestricted Access
    Kidney Function and Plasma Copeptin Levels in Healthy Kidney Donors and Autosomal Dominant Polycystic Kidney Disease Patients
    Debbie Zittema, Else van den Berg, Esther Meijer, Wendy E. Boertien, Anneke C. Muller Kobold, Casper F.M. Franssen, Paul E. de Jong, Stephan J.L. Bakker, Gerjan Navis and Ron T. Gansevoort
    CJASN September 2014, 9 (9) 1553-1562; DOI: https://doi.org/10.2215/CJN.08690813
    Add to Selected Citations

Articles

  • Current Issue
  • Early Access
  • Subject Collections
  • Article Archive
  • ASN Meeting Abstracts

Information for Authors

  • Submit a Manuscript
  • Trainee of the Year
  • Author Resources
  • ASN Journal Policies
  • Reuse/Reprint Policy

About

  • CJASN
  • ASN
  • ASN Journals
  • ASN Kidney News

Journal Information

  • About CJASN
  • CJASN Email Alerts
  • CJASN Key Impact Information
  • CJASN Podcasts
  • CJASN RSS Feeds
  • Editorial Board

More Information

  • Advertise
  • ASN Podcasts
  • ASN Publications
  • Become an ASN Member
  • Feedback
  • Follow on Twitter
  • Password/Email Address Changes
  • Subscribe to ASN Journals

© 2022 American Society of Nephrology

Print ISSN - 1555-9041 Online ISSN - 1555-905X

Powered by HighWire